2010, Conflict of Interest, Ethics and Health Care

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2010

Conflict of Interest

Ethics

Health Care

Big Pharma's Hidden Business Model and How Your Company Funds It

Harvard Business Review

SEPTEMBER 12, 2012

Since companies test their own products—an obvious conflict of interest—they naturally design clinical trials to maximize evidence that they are beneficial and minimize evidence they are harmful. Safra Center for Ethics , some fellows study how these institutional practices corrupt medical science and clinical practice.

Business Model

Business Model Company Pharmaceuticals Price

How Pharma Can Fix Its Reputation and Its Business at the Same Time

Harvard Business Review

FEBRUARY 3, 2017

The estimated return on these (fewer) products has itself declined substantially since 2010, from 10.1% Ethical conduct is particularly important in emerging markets where companies rely heavily on governments’ goodwill for market access and health care investments. Enhance corporate reputations.

Reputation

Reputation Pharmaceuticals Price Business Model

Leadership Digital

Big Pharma's Hidden Business Model and How Your Company Funds It

How Pharma Can Fix Its Reputation and Its Business at the Same Time

Stay Connected